Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :17935213
Publication Date : //

Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families.


Arterial tortuosity syndrome (ATS) is a rare autosomal recessive connective tissue disease, characterized by widespread arterial involvement with elongation, tortuosity, and aneurysms of the large and middle-sized arteries. Recently, SLC2A10 mutations were identified in this condition. This gene encodes the glucose transporter GLUT10 and was previously suggested as a candidate gene for diabetes mellitus type 2. A total of 12 newly identified ATS families with 16 affected individuals were clinically and molecularly characterized. In addition, extensive cardiovascular imaging and glucose tolerance tests were performed in both patients and heterozygous carriers. All 16 patients harbor biallelic SLC2A10 mutations of which nine are novel (six missense, three truncating mutations, including a large deletion). Haplotype analysis suggests founder effects for all five recurrent mutations. Remarkably, patients were significantly older than those previously reported in the literature (P=0.04). Only one affected relative died, most likely of an unrelated cause. Although the natural history of ATS in this series was less severe than previously reported, it does indicate a risk for ischemic events. Two patients initially presented with stroke, respectively at age 8 months and 23 years. Tortuosity of the aorta or large arteries was invariably present. Two adult probands (aged 23 and 35 years) had aortic root dilation, seven patients had localized arterial stenoses, and five had long stenotic stretches of the aorta. Heterozygous carriers did not show any vascular anomalies. Glucose metabolism was normal in six patients and eight heterozygous individuals of five families. As such, overt diabetes is not related to SLC2A10 mutations associated with ATS.

Authors : Callewaert B L , Willaert A , Kerstjens-Frederikse W S , De Backer J , Devriendt K , Albrecht B , Ramos-Arroyo M A , Doco-Fenzy M , Hennekam R C M , Pyeritz R E , Krogmann O N , Gillessen-kaesbach G , Wakeling E L , Nik-zainal S , Francannet C , Mauran P , Booth C , Barrow M , Dekens R , Loeys B L , Coucke P J , De Paepe A M ,

Related products :

Catalog number Product name Quantity
32-236 Visfatin, a newly identified adipocytokine ,which is predominantly secreted from visceral adipose tissue both in humans and mice . Visfatin corresponds to a protein identified previously as pre-B cell 0.1 mL
orb82727 Human IL29 protein IL28A, IL28B, and IL29, also named interferon-λ2 (IFN-λ2), IFN-λ3, and IFN-λ1, respectively, are newly identified class II cytokine receptor ligands that are distantlyrelated to mem 1 mg
orb82616 Human IL29 protein IL28A, IL28B, and IL29, also named interferon lambda2 (IFN lambda 2), IFN lambda 3, and IFN lambda 1, respectively, are newly identified class II cytokine receptor ligands that are 5
EIAAB36563 Bos taurus,Bovine,CAAF1,CAAF1,CAGC,Calcium-binding protein in amniotic fluid 1,Calgranulin-C,CO-AG,Cornea-associated antigen,EN-RAGE,Extracellular newly identified RAGE-binding protein,Protein S100-A1
EIAAB36561 CAGC,Calgranulin-C,EN-RAGE,Extracellular newly identified RAGE-binding protein,Oryctolagus cuniculus,Protein S100-A12,Rabbit,S100 calcium-binding protein A12,S100A12
EIAAB36562 CAGC,Calgranulin-C,EN-RAGE,Extracellular newly identified RAGE-binding protein,Pig,Protein S100-A12,S100 calcium-binding protein A12,S100A12,Sus scrofa
EIAAB36560 CAAF1,CAGC,Calcium-binding protein in amniotic fluid 1,Calgranulin-C,CGRP,EN-RAGE,Extracellular newly identified RAGE-binding protein,Homo sapiens,Human,Neutrophil S100 protein,p6,Protein S100-A12,S10
65-102 anti_SARS antibody(clone 3A2) A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and 250 ug
65-101 anti_SARS antibody(clone 3A2) A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and 50 ug
27-480 MEFV was identified as the gene that when mutated causes Mediterranean fever, a hereditary periodic fever syndrome. MEFV is expressed in granulocytes and myeloid bone marrow precursors. 0.1 mg
28-343 MTA2 has been identified as a component of NuRD, a nucleosome remodeling deacetylase complex identified in the nucleus of human cells. It shows a very broad expression pattern and is strongly expresse 0.05 mg
28-882 MTA2 has been identified as a component of NuRD, a nucleosome remodeling deacetylase complex identified in the nucleus of human cells. It shows a very broad expression pattern and is strongly expresse 0.1 mg
25-907 Retrovirus receptors allow infection of human and murine cells by various retroviruses. The receptors that have been identified at the molecular level include CD4 (MIM 186940) for human immunodeficien 0.05 mg
TM 074 COLUMBIA C.N.A. AGAR BASE (Store below 8º C) (for selective isolation of gram positive cocci from clinical and non clinical samples.) 500 gm
orb60065 ABT-869 ABT-869(Linifanib) is a structurally novel, potent RTK and VEGF and PDGF receptor families inhibitor with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGFR-beta, KDR, and CSF-1R, 10 mg
KMCHS4E Arterial Arm Stick Kit
KMCS3A Arterial Arm Stick Kit
KMMS6 Arterial Puncture Arm Simulator 6
KMMS6 Arterial Puncture Arm Simulator
KMS07 Arterial venipuncture arm for baby Set
TA593 Normal Control for Clinical Chemistry, Lyophilized, Bovine Source, 5ml_vial, Clinical Chemistry Kits 10
TA592 Pathological Control for Clinical Chemistry, Lyophilized, Human Source, 5ml_vial, Clinical Chemistry Kits 5
TA594 Normal Control for Clinical Chemistry, Lyophilized, Human Source, 5ml_vial, Clinical Chemistry Kits 5
TA591 Pathological Control for Clinical Chemistry, Lyophilized, Bovine Source, 5ml_vial, Clinical Chemistry Kits 10
KMMS50 Rotated Arterial Puncture Arm Simulator


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur